AffirmHealth Blog

blog-image

First Federal Charges Issued Against a Drug Manufacturer

May 7, 2019 8:17:27 AM by AffirmHealth

In an effort to reduce overprescribing of opioids nationwide, there has been serious crackdowns on physicians, pharmacists, and manufacturers in the industry to help control prescribing rates and their roles in contributing to the epidemic. Yet for the first time, federal charges were issued against a drug manufacturer last month.    

Read More
blog-1

The Role of Veterinary Prescribing in the National Opioid Epidemic

Apr 30, 2019 9:30:00 AM by AffirmHealth

The opioid epidemic has been an ever-present, evolving issue across the United States over the past two decades. Efforts to address the misuse of opioids have ranged from prescriber education and state-led drug take back programs to novel pain treatments and new opioid prescribing regulations

Read More
analytics_0

The Evolution of Health Tech Aimed at the Opioid Crisis

Apr 18, 2019 8:30:00 AM by Mario Ramirez, MD

One of our recent posts, “Prescribing Intelligence: The Role of Data Analytics in Combatting the Opioid Epidemic,” focused on the usefulness of data within clinical decision support tools to help clinicians at the patient bedside.  In that article, we made the key point that “analyzing and accurately indexing data” is a critical hurdle that must be crossed if big data is going to be useful for clinical care delivery.  

Read More
bigstock-Skyline-Of-Downtown-Charlotte--185476741

The Rural-Urban Opioid Divide and the Space In-Between

Mar 26, 2019 10:00:00 AM by Mario Ramirez, MD posted in Opioid Epidemic, fentanyl, controlled substances

In my day to day emergency medicine practice, I routinely treat and manage opioid related overdoses, sometimes as frequently as three or four patients a day. And while the emergency clinical care of an opioid overdose is the same in rural, suburban, and urban emergency departments, I’ve often felt myself wondering what it is that drives the differences in these groups.

Read More
opioidanalytics

Prescribing Intelligence: The Role of Data Analytics in Combatting the Opioid Epidemic

Mar 13, 2019 9:27:00 AM by John Cole

The opioid epidemic continues to wreak havoc on the public’s health, wellbeing, and its wallet. In recent years, the regulatory efforts to stem the crisis have significantly decreased opioid prescribing, but not without a cost. Clinicians who prescribe opioids are acutely aware of the regulatory oversight intended to cut down overprescribing, and this has stoked a “climate of fear” when prescribing. As such, patients suffering from chronic pain who have relied on opioid medications for years have reported that their physicians have either stopped prescribing opioids entirely or involuntarily tapered them to doses that do not adequately address their pain.

Read More
bigstock-Generic-Prescription-Medicine--244270003-1

Opioids & Driving: Know the Risks

Feb 25, 2019 2:03:00 PM by Jody Lutz

At AffirmHealth we have focused extensively on covering  our nation's drug crisis -- it’s impact on patients,  physicians and their practices. We have studied the changing laws and dynamics around how practitioners prescribe and the resulting effect on patients. Today we are taking the discussion to the open road, a topic that has been covered by many a country and western ballad and is part of the American way of life.

Read More
bigstock-Doctor-With-Medical-Healthcare-213017662

HHS Interagency Task Force on Pain Management Attracts Some Controversy

Feb 12, 2019 3:00:00 PM by Mario Ramirez, MD posted in Pain Management, regulations

 

Task Force Releases Draft Report

The Comprehensive Addiction and Recovery Act of 2016 established a Pain Management Best Practices Inter-Agency Task Force, chaired by Dr. Vanila Singh, under the oversight of the U.S. Department of Health and Human Services.

Read More
Shield Logo_Blog Resized

We've launched Shield on the athenahealth Marketplace

Jan 31, 2019 8:33:00 AM by Mitch Evans

The Shield platform now integrates with athenaClinicals to help medical group leaders proactively manage and measure opioid prescribing, so they can have the assurance of responsible prescribing across the organization.

Read More

The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.

Comments